Kadimastem Submits IND Application to the FDA for its Phase IIa Clinical Trial with AstroRx for the Treatment of ALS  Marketscreener.com

See more here:

Kadimastem Submits IND Application to the FDA for its Phase IIa Clinical Trial with AstroRx for the Treatment of ALS - Marketscreener.com

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh